Omnicell (OMCL) EBT Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Omnicell (OMCL) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -719.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 236.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 295.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 687.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 88.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 374.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -938.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 343.00 |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -158.00 |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 724.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 724.00 |
| Mar 31, 2026 | 899.00 |
| Dec 31, 2025 | -747.00 |
| Sep 30, 2025 | -99.00 |
| Jun 30, 2025 | 64.00 |
| Mar 31, 2025 | 371.00 |
| Dec 31, 2024 | 1,484.00 |
| Sep 30, 2024 | 165.00 |
| Jun 30, 2024 | -112.00 |
| Mar 31, 2024 | 4.00 |
| Dec 31, 2023 | 478.00 |
| Sep 30, 2023 | -250.00 |
| Jun 30, 2023 | 83.00 |
| Mar 31, 2023 | -885.00 |
| Dec 31, 2022 | -1,412.00 |
| Sep 30, 2022 | -289.00 |
| Jun 30, 2022 | -517.00 |
| Mar 31, 2022 | -357.00 |
| Dec 31, 2021 | -338.00 |
| Sep 30, 2021 | 274.00 |